Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
The gross margin is 0.00% as of the fiscal period ended Tuesday, June 30, 2026.
Reported quarterly gross margin; no daily interpolation. Q3 FY2026 (2026-06-30): 0.00%.
GROSS MARGIN
0.00%
GROSS MARGIN AVG TTM
0.00%
GROSS MARGIN AVG 3Y
0.00%
GROSS MARGIN AVG 5Y
0.00%
GROSS MARGIN AVG 10Y
0.00%
GROSS MARGIN AVG 15Y
-17.88%
GROSS MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
+100.00%
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
42.91%
median of 612 covered companies
CURRENT VS SECTOR MEDIAN
-100.00%
vs the sector median at left
Market Cap
$36.38M
Gross Margin
62.59%
TTM Avg
69.78%
3Y Avg
74.14%
5Y Avg
76.12%
Market Cap
$36.29M
Gross Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
22.09%
Market Cap
$35.75M
Gross Margin
27.73%
TTM Avg
29.89%
3Y Avg
31.55%
5Y Avg
33.94%
Market Cap
$39.28M
Gross Margin
58.16%
TTM Avg
55.59%
3Y Avg
55.93%
5Y Avg
56.24%
Market Cap
$38.21M
Gross Margin
0.00%
TTM Avg
-93.03%
3Y Avg
-21.51%
5Y Avg
10.85%
| NAME | MARKET CAP | GROSS MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Edesa Biotech, Inc. (EDSA) | $37.23M | 0.00% | 0.00% | 0.00% | 0.00% |
| iTonic Holdings Ltd. (ITOC)vs › | $36.38M | 62.59% | 69.78% | 74.14% | 76.12% |
| DocGo Inc. (DCGO)vs › | $36.48M | 30.12% | 32.64% | 32.93% | 33.24% |
| Elicio Therapeutics, Inc. (ELTX)vs › | $36.29M | 0.00% | 0.00% | 0.00% | 22.09% |
| Accuray Incorporated (ARAY)vs › | $35.75M | 27.73% | 29.89% | 31.55% | 33.94% |
| Harvard Bioscience, Inc. (HBIO)vs › | $39.28M | 58.16% | 55.59% | 55.93% | 56.24% |
| Elutia Inc (ELUT)vs › | $34.92M | 57.82% | 48.80% | 47.77% | 46.56% |
| Nephros, Inc. (NEPH)vs › | $39.63M | 60.31% | 61.36% | 57.30% | 56.95% |
| Incannex Healthcare Limited (IXHL)vs › | $38.21M | 0.00% | -93.03% | -21.51% | 10.85% |
| BriaCell Therapeutics Corp. (BCTX)vs › | $34.89M | 0.00% | 0.00% | 0.00% | 0.00% |
Gross Margin
0.0%
(Revenue - COGS) / Revenue
Gross Margin = Gross Profit / Revenue
Gross margin is the percentage of revenue remaining after the cost of goods sold, reflecting core product profitability.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | GROSS MARGIN |
|---|---|
| 2026-06-30 | 0.00% |
| 2026-03-31 | 0.00% |
| 2025-12-31 | 0.00% |
| 2025-09-30 | 0.00% |
| 2025-06-30 | 0.00% |
| 2025-03-31 | 0.00% |
| 2024-12-31 | 0.00% |
| 2024-09-30 | 0.00% |
| 2024-06-30 | 0.00% |
| 2024-03-31 | 0.00% |
| 2023-12-31 | 0.00% |
| 2023-09-30 | 0.00% |
| 2023-06-30 | 0.00% |
| 2023-03-31 | 0.00% |
| 2022-12-31 | 0.00% |
| 2022-09-30 | 0.00% |
| 2022-06-30 | 0.00% |
| 2022-03-31 | 0.00% |
| 2021-12-31 | 0.00% |
| 2021-09-30 | 0.00% |
| 2021-06-30 | 0.00% |
| 2021-03-31 | 0.00% |
| 2020-12-31 | 0.00% |
| 2020-09-30 | -362.80% |
| 2020-06-30 | 98.66% |
| 2020-03-31 | 90.92% |
| 2019-12-31 | 96.50% |
| 2019-09-30 | 99.98% |
| 2019-06-30 | 100.00% |
| 2019-03-31 | 15.26% |
| 2018-12-31 | -100.39% |
| 2018-09-30 | -64.61% |
| 2018-06-30 | -57.57% |
| 2018-03-31 | -118.65% |
| 2017-12-31 | -392.27% |
| 2017-09-30 | -3161.98% |
| 2017-06-30 | -592.88% |
| 2017-03-31 | -113.98% |
| 2016-12-31 | -15.19% |
| 2016-09-30 | 26.24% |
| 2016-06-30 | 1.13% |
| 2016-03-31 | -6.68% |
| 2015-12-31 | 18.68% |
| 2015-09-30 | 66.25% |
| 2015-06-30 | -80.95% |
| 2015-03-31 | -65.22% |
| 2014-12-31 | 16.72% |
| 2014-08-31 | -240.65% |
| 2014-05-31 | -31.95% |
| 2014-02-28 | -6.33% |
| 2013-11-30 | -105.70% |
| 2013-08-31 | 28.78% |
| 2013-05-31 | -39.27% |
| 2013-02-28 | -64.20% |
| 2012-11-30 | -41.26% |
| 2012-08-31 | 172.58% |
| 2012-05-31 | -122.98% |
| 2012-02-29 | -148.76% |
| 2011-11-30 | -70.67% |
| 2011-08-31 | -1300.67% |
| 2011-05-31 | -209.82% |
| 2011-02-28 | 68.95% |
| 2010-11-30 | -125.94% |
| 2010-08-31 | 82.41% |
| 2010-05-31 | 30.62% |
| 2010-01-31 | 0.00% |
| 2009-10-31 | 0.00% |
| 2009-04-30 | 0.00% |
| 2009-01-31 | 0.00% |
| 2008-10-31 | 0.00% |
